Express News | Pharming's Phase III Study Highlights Leniolisib's Potential To Transform Treatment For Pediatric APDS Patients (Ages 4-11)

Benzinga01:26 ET

Construction Output to Hit Upper Range of $34-37b in FY24

Singapore Business Review21:14 ET

Ageson Bhd To Rebrand As TXCD Bhd

Business TodayDec 9 23:39 ET

NTUC to Raise Retirement, Re-employment Ages in 2025

Singapore Business ReviewDec 9 21:40 ET

Stuff Those Stockings With Skin Care Solutions

PR NewswireDec 2 09:00 ET

Express News | AGES Reports FY25Q1 Revenue of RM13.81 Million

Moomoo NewsNov 29 04:22 ET · Earnings